From July 1, 2023 to September 20, 2023, the company has repurchased 7,669,100 shares, representing 0.64% for CNY 81.02 million. With this, the company has completed the repurchase of 18,489,100 shares, representing 1.55% for CNY 194.73 million under the buyback announced on September 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 CNY | -0.95% | -2.69% | -11.22% |
16/05 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
29/04 | Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.22% | 1.37B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.